Search

Search Constraints

You searched for: Author/Creator Halfon, Philippe

Search Results

1. A Granulocytic Signature Identifies COVID-19 and Its Severity. (17th September 2020)

2. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. Issue 2 (3rd March 2016)

3. Baseline and Post-Treatment Hepatitis C NS5A Resistance in Relapsed Patients from a Multicentric Real-Life Cohort. Issue 4 (May 2018)

5. Comparison of oncogenic HPV type‐specific viral DNA load and E6/E7 mRNA detection in cervical samples: Results from a multicenter study. Issue 3 (26th December 2012)

6. Cytolytic hepatitis related to simeprevir overdose in a patient with cirrhosis and HIV–HCV genotype 1 coinfection. Issue 4 (April 2016)

7. Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients. Issue 10 (October 2019)

8. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. (July 2020)

9. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions. Issue 3 (4th March 2022)